Novartis To Slash 1960 US Jobs; Glenmark Projects 20% Growth In Sales
Drug manufacturer Novartis will slash around 1,960 jobs in US during 2012 in expectancy of lower sales for two of its high blood pressure medications.
Savient Pharmaceuticals has roped in David Veitch President of Savient Europe with effect from January 16, 2012.
Glenmark Pharmaceuticals projects sales of its speciality biz, which concentrates on branded products, to develop by about 20% in the Indian market by the
coming three years (2015).
Fleming Pharmaceuticals has sold four of its well known brands, comprising Ocean nasal spray, to a division of a Canadian drug firm.
